98 related articles for article (PubMed ID: 8658213)
1. Pathologic and phenotypic features of gastric cancer.
Fenoglio-Preiser CM; Noffsinger AE; Belli J; Stemmermann GN
Semin Oncol; 1996 Jun; 23(3):292-306. PubMed ID: 8658213
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Panani AD
Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
4. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer.
Kong U; Koo J; Choi K; Park J; Chang H
Hepatogastroenterology; 2004; 51(59):1519-23. PubMed ID: 15362791
[TBL] [Abstract][Full Text] [Related]
5. Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations.
Schwartz GK
Semin Oncol; 1996 Jun; 23(3):316-24. PubMed ID: 8658215
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
7. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
8. Molecular biological observations in gastric cancer.
Tahara E; Semba S; Tahara H
Semin Oncol; 1996 Jun; 23(3):307-15. PubMed ID: 8658214
[TBL] [Abstract][Full Text] [Related]
9. Pathology and molecular biology of gastric cancer.
Vauhkonen M; Vauhkonen H; Sipponen P
Best Pract Res Clin Gastroenterol; 2006; 20(4):651-74. PubMed ID: 16997151
[TBL] [Abstract][Full Text] [Related]
10. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
12. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
13. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinases and gastric cancer.
Lin W; Kao HW; Robinson D; Kung HJ; Wu CW; Chen HC
Oncogene; 2000 Nov; 19(49):5680-9. PubMed ID: 11114748
[TBL] [Abstract][Full Text] [Related]
17. Lower- and higher-grade subtypes of diffuse gastric cancer.
Chiaravalli AM; Klersy C; Tava F; Manca R; Fiocca R; Capella C; Solcia E
Hum Pathol; 2009 Nov; 40(11):1591-9. PubMed ID: 19540560
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
19. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
20. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
